Hesham Ahmed Abdullah is Senior Vice President, Global Head of Oncology, Research & Development at GSK, where he oversees the end-to-end strategic development of GSK’s Oncology portfolio. Hesham is a proven global drug developer, whose leadership and oversight responsibilities have led to the development and registration of more than 12 precision oncology medicines, while setting numerous drug development precedents along the way. Hesham is a seasoned physician-scientist and senior executive with wide-ranging experiences in the biopharmaceutical industry, ranging across advanced technologies, translational science and multiple disciplines as well as early & late stages of R&D and solid & hematological malignancies. He has an established and successful track record of building high performing global organizations, in complex & highly matrixed environments. Hesham has over 20 years of global Oncology & Immuno-Oncology drug development experience, with roles of increasing leadership and responsibilities in the large biopharma sector.